$60 a share seems like a conservative estimate

$Pfizer(PFE)$ PFE appears to be doing everything right. They have a solid stable of approved drugs, a strong pipeline, and billions of dollars in COVID related vaccines and treatments. They are using the money to add on promising biotechs to support their drug development efforts. Keeping their solid dividend is also a plus as they originally were going to reduce it by what VTRS was going to pay after acquiring PFE's generic business. $60 a share seems like a conservative estimate in 22.

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

举报

评论

  • 推荐
  • 最新
empty
暂无评论